Evidence map›Paper›PMID 25246397›Full record

ArticleAntimicrobial agents and chemotherapy2014

A drug-repositioning screening identifies pentetic acid as a potential therapeutic agent for suppressing the elastase-mediated virulence of Pseudomonas aeruginosa.

Mia Gi, Junhui Jeong, Keehoon Lee, Kang-Mu Lee, Masanori Toyofuku, Dong Eun Yong, Sang Sun Yoon, Jae Young Choi

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Chemical Optimization of SelectiveACS infectious diseases · 2023
    Article
  2. Review
  3. The Molecular Architecture ofMarine drugs · 2022
    Review
  4. Curvularin Isolated FromFrontiers in microbiology · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. DisarmingFrontiers in microbiology · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mia GiDepartment of Otorhinolaryngology, Brain Korea 21 PLUS Project for Medical Science, Seoul, South Korea.
Junhui JeongDepartment of Otorhinolaryngology, Brain Korea 21 PLUS Project for Medical Science, Seoul, South Korea.
Keehoon LeeDepartment of Microbiology and Immunology, Brain Korea 21 PLUS Project for Medical Science, Seoul, South Korea.
Kang-Mu LeeDepartment of Microbiology and Immunology, Brain Korea 21 PLUS Project for Medical Science, Seoul, South Korea.
Masanori ToyofukuGraduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Dong Eun YongDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Sang Sun YoonDepartment of Microbiology and Immunology, Brain Korea 21 PLUS Project for Medical Science, Seoul, South Korea Institute for Immunology and Immunological Diseases, Seoul, South Korea sangsun_yoon@yuhs.ac jychoi@yuhs.ac.
Jae Young ChoiDepartment of Otorhinolaryngology, Brain Korea 21 PLUS Project for Medical Science, Seoul, South Korea sangsun_yoon@yuhs.ac jychoi@yuhs.ac.
Korea Institute of Brain Science · KRUniversity of Tsukuba · JPYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas aeruginosa, a Gram-negative bacterium of clinical significance, produces elastase as a predominant exoprotease. Here, we screened a library of chemical compounds currently used for human medication and identified diethylene triamine penta-acetic acid (DTPA, pentetic acid) as an agent that suppresses the production of elastase. Elastase activity found in the prototype P. aeruginosa strain PAO1 was significantly decreased when grown with a concentration as low as 20 μM DTPA. Supplementation with Zn(2+) or Mn(2+) ions restored the suppressive effect of DTPA, suggesting that the DTPA-mediated decrease in elastase activity is associated with ion-chelating activity. In DTPA-treated PAO1 cells, transcription of the elastase-encoding lasB gene and levels of the Pseudomonas quinolone signal (PQS), a molecule that mediates P. aeruginosa quorum sensing (QS), were significantly downregulated, reflecting the potential involvement of the PQS QS system in DTPA-mediated elastase suppression. Biofilm formation was also decreased by DTPA treatment. When A549 alveolar type II-like adenocarcinoma cells were infected with PAO1 cells in the presence of DTPA, A549 cell viability was substantially increased. Furthermore, the intranasal delivery of DTPA to PAO1-infected mice alleviated the pathogenic effects of PAO1 cells in the animals. Together, our results revealed a novel function for a known molecule that may help treat P. aeruginosa airway infection.

Indexed as

Administration, IntranasalAnimalsAnti-Bacterial AgentsBacterial ProteinsBiofilmsCations, DivalentCell Line, TumorDrug RepositioningEnzyme InhibitorsHumansIron Chelating AgentsMaleManganeseMetalloendopeptidasesMicePentetic Acid2-heptyl-3-hydroxy-4-quinoloneAnti-Bacterial AgentsBacterial ProteinsCations, DivalentEnzyme InhibitorsIron Chelating AgentsManganeseMetalloendopeptidasesPentetic Acidpseudolysin, Pseudomonas aeruginosaQuinolonesSmall Molecule LibrariesZinc

Identifiers

PMID25246397
PMCPMC4249511
OpenAlexW2011009421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.